Ongoing research is focused on identifying new cancer dependencies and developing drugs to target them. Advances in genomics and proteomics are aiding in the discovery of novel dependencies. Additionally, patient-derived xenografts and organoids are being used to study cancer dependencies in a more physiologically relevant context.
